Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation

Carbohydr Polym. 2017 Dec 1:177:49-57. doi: 10.1016/j.carbpol.2017.08.058. Epub 2017 Aug 18.

Abstract

The objective of this study was to develop a new approach for fabrication of zero order release of active pharmaceutical ingredients (APIs) using hot-melt extrusion (HME) and 3D printing technology to generate tablets with specific 3D structures. By correlating the geometry of the 3D printed tablets with their dissolution and drug release rates, mathematical models that have been developed to describe drug release mechanisms were also studied. Acetaminophen was used as a model drug, and Benecel™ hydroxypropyl methylcellulose (HPMC) E5 and Soluplus® were used to formulate nine fuse depositional 3D-printed tablets with different inner core fill densities and outside shell thicknesses. This work reports the successful fabrication of solid-dispersion filaments with an API dispersed in HPMC based matrix via HME technology, and the production of zero order controlled release tablets with different 3D structures (tablets #3, 5, 6, and 9) using a 3D printer.

Keywords: Acetaminophen; Controlled release; Dissolution kinetics; Fused deposition modeling 3D printing; Hot-melt extrusion; Hydroxypropyl methylcellulose.

MeSH terms

  • Delayed-Action Preparations / chemistry*
  • Hypromellose Derivatives / chemistry
  • Methylcellulose / chemistry*
  • Printing, Three-Dimensional*
  • Solubility
  • Tablets / chemistry
  • Technology, Pharmaceutical / methods*
  • Technology, Pharmaceutical / standards

Substances

  • Delayed-Action Preparations
  • Tablets
  • Hypromellose Derivatives
  • Methylcellulose